Thursday, July 11, 2013
Publication and contact
Intestinal organoid model
fibrosis transmembrane conductance regulator (CFTR)
An intestinal organoid
model for CFTR function could help develop compounds to treat cystic
fibrosis. Organoids were cultured from human intestinal stem cells and
treated with forskolin, which activates CFTR and
induces fluid influx and swelling. In organoids cultured from patients
carrying mutant CFTR variants, forskolin-induced swelling was lower than that
in patients carrying wild-type CFTR. In DF508 mutant CFTR-expressing
organoids, compounds that increased CFTR function also increased
forskolin-induced swelling compared with vehicle. Next steps include using
the organoids to model patient response to CFTR-targeted drugs.
Pharmaceuticals Inc.'s VX-809,
a CFTR corrector, is in Phase III trials to treat DF508
mutant cystic fibrosis (CF) in combination with the CFTR potentiator Kalydeco
Vertex markets Kalydeco to treat CF.
Published online July 11, 2013
Patent application filed;
available for licensing
Dekkers, J.F. et al.
Nat. Med.; published online June 2, 2013;
Contact: Jeffrey M. Beekman, University Medical Center
Utrecht, Utrecht, the Netherlands
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]